James Crosby (@Jamesac19) profile picture

Commissioning Team Manager - Medicine and Health Journals Taylor & Francis Opinions are my own

London, England
Joined March 2010
Photo by James Crosby (@Jamesac19)Photo by James Crosby (@Jamesac19)
Delighted to share that the 𝐉𝐨𝐮𝐫𝐧𝐚𝐥 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬 is partnered with the 𝐖𝐨𝐫𝐥𝐝 𝐄𝐏𝐀 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 in 2025. To discover more about the conference use the link below 👇 terrapinn.com/epa/IJME #healtheconomics #medicaleconomics #HEOR #RWE
4
4
327
Today we are welcoming ASN Neuro to the T&F Neurology journals portfolio! 🥳 spr.ly/6018iDc6p @ASNeurochem #ASNeuro
1
4
3
517
🚨New Supplement🚨 Delighted to announce publication of our latest supplement on #SystemicLupusErythematosus. Click the link below for full access to the articles 👇 bit.ly/3Tq6Rn9 #HEOR #healtheconomics #pharmacoeconomics #healthcare
3
6
395
The special focus issue on Anticoagulation in Expert Review of Cardiovascular Medicine is now live! 📚 Dive into the latest advancements and perspectives in the world of anticoagulation🩸👇 #CardiovascularMedicine #Anticoagulation #ExpertReview tandfonline.com/toc/ierk20/2…
2
3
141
📢New article alert! I sat down with @drflett to discuss #heartfailure in the UK. He shares his expertise on treatment, cardiac devices and future outlooks...a must-read for anyone interested in #cardiovascular health! 💙 Read the interview for free 👇 tandfonline.com/doi/full/10.…
3
1
6
723
📢 2 weeks remaining to submit your application for the Editor-in-Chief position of #ExpertOpiniononOrphanDrugs 📢
We're recruiting for an Editor-in-Chief to lead Expert Opinion on Orphan Drugs, an international journal publishing rigorously peer-reviewed review articles and original papers on #RareDiseases and #OrphanDrugs 💉💊
1
4
5
523
Elevated Lipoprotein(a) is the latest variant of ‘bad cholesterol’ found to increase the risk of recurrent coronary heart disease. Findings, published by @UNSWMedicine researchers in @CMRO_Journal, show it is an important CHD predictor in people 60+⚠️ spr.ly/6014OLHti
6
1
10
649
🚨 New special issue now online 🚨 Read our latest special issue, which delves further into the different aspects surrounding #Vasculitis. The issue is freely available for everyone to read until next month. Click here to read the full articles now ➡️ tandfonline.com/toc/ipgm20/1…
7
10
923
🚨Special issue update🚨 We have released the first article online titled "Advancing towards a worldwide #healthcare system in the post #COVID19 era: benefits and barriers to international collaboration in healthcare". Available here 👉 bit.ly/3OVXoTX #Healtheconomics
1
3
4
217
Looking forward to heading to Glasgow for #WCP2023 in a months time 💊 Please reach out if you would like to discuss the #ExpertCollection journals, #AcceleratedPublication and/or #PlainLanguageSummaries that Taylor & Francis Group has to offer 👋 wcp2023.org/
5
1
6
519
ISPOR 2023, the leading global conference for health economics and outcomes research (#HEOR), May 7-10 at the Boston Convention & Exhibition Center, Boston, MA, USA. Hear the latest hot topics and trends in #HEOR. #ISPORAnnual Click the link for more 👉 ow.ly/mWGB50Of6m2
4
6
251
ISPOR 2023, the leading global conference for health economics and outcomes research (#HEOR), May 7-10 at the Boston Convention & Exhibition Center, Boston, MA, USA. Hear the latest hot topics and trends in #HEOR. #ISPORAnnual click the link for more 👉ow.ly/mWGB50Of6m2
7
9
594
🚨 How can digital endpoints empower patients? 🚨 WELCOMING SUBMISSIONS at Expert Review of Pharmacoeconomics & Outcomes Research in collaboration with Guest Advisor Katarzyna Kolasa. 👇 Learn more at the link below 👇 #digitalhealth think.taylorandfrancis.com/i…
2
1
76
Delighted to share a recent supplement, which has been published in Postgraduate Medicine, on "#Semaglutide for #weight management – an introduction for primary care." Click here to read the full supplement ➡️ tandfonline.com/toc/ipgm20/1… #WeightManagement #Obesity #PrimaryCare
4
7
318
We are excited to share this special focus issue on JAK inhibitors in autoimmune and inflammatory diseases in Expert Review of Clinical Immunology #immunology #rheumatology #jakinhibitors tandfonline.com/toc/ierm20/c…
2
2
To start we would love to know what field you work in to establish who is benefiting most from the 2022 CHEERS statement. Please select one of the options or leave a comment below. #JMECHEERS2022 View the statement here 👉 https://teapawt.net/t.co/s5BHuFrjKx
50%Researcher
33%Editor
17%Peer reviewer
0%Health professional
6 votes • Final results
5
4
Discover more about our latest article, economic evaluation of polatuzumab-bendamustine-rituximab vs. tafasitamab-lenalidomide in transplant-ineligible R/R DLBCL, in this interview with the author Dr. Matthias Calamia. #oncology Click the link for more: https://teapawt.net/t.co/ZbPsiKOgq1
2
2